Agilon Health, Inc. (AGL)
86.83
-2.67
(-2.98%)
USD |
NYSE |
Nov 20, 10:35
Agilon Health Cash from Operations (Quarterly) : 49.87M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 49.87M |
| June 30, 2026 | -57.30M |
| March 31, 2026 | 22.12M |
| December 31, 2025 | -20.54M |
| September 30, 2025 | -18.15M |
| June 30, 2025 | -35.08M |
| March 31, 2025 | -31.99M |
| December 31, 2024 | 16.42M |
| September 30, 2024 | -7.703M |
| June 30, 2024 | -18.72M |
| March 31, 2024 | -47.78M |
| December 31, 2023 | -61.17M |
| September 30, 2023 | -13.02M |
| June 30, 2023 | -21.20M |
| Date | Value |
|---|---|
| March 31, 2023 | -60.81M |
| December 31, 2022 | -49.96M |
| September 30, 2022 | 2.647M |
| June 30, 2022 | -60.26M |
| March 31, 2022 | -23.23M |
| December 31, 2021 | -48.90M |
| September 30, 2021 | -19.14M |
| June 30, 2021 | -39.29M |
| March 31, 2021 | -40.83M |
| December 31, 2020 | -13.34M |
| September 30, 2020 | -4.367M |
| June 30, 2020 | -9.371M |
| March 31, 2020 | -26.13M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Astrana Health, Inc. | 16.27M |
| Starling Oncology, Inc. | 10.14M |
| Nakamoto, Inc. | -10.28M |
| American Oncology Network, Inc. | -- |
| Biodesix, Inc. | -7.203M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 17.82M |
| Cash from Financing (Quarterly) | -0.124M |
| Free Cash Flow | -26.29M |
| Free Cash Flow Per Share (Quarterly) | 2.635 |
| Free Cash Flow to Equity (Quarterly) | 46.64M |
| Free Cash Flow to Firm (Quarterly) | 48.18M |
| Free Cash Flow Yield | -1.80% |